Announcements Trials

Browse Landscape

Phase

Status

Terminated 2 Completed 2 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 20 Lung Neoplasms 15 Carcinoma, Hepatocellular 13 Urinary Bladder Neoplasms 11 Colorectal Neoplasms 11 Small Cell Lung Carcinoma 9 Neoplasms 8 Carcinoma, Transitional Cell 8 Stomach Neoplasms 7 Neoplasm Metastasis 7 Breast Neoplasms 6 Triple Negative Breast Neoplasms 5 Melanoma 5 Prostatic Neoplasms 4 Glioblastoma 4 Carcinoma, Renal Cell 4 Uterine Cervical Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Ovarian Neoplasms 3 Carcinoma, Neuroendocrine 3 Urethral Neoplasms 2 Ureteral Neoplasms 2 Turcot syndrome 2 Solid Tumors 2 Rectal Neoplasms 2 Pancreatic Neoplasms 2 Nasopharyngeal Carcinoma 2 Mesothelioma, Malignant 2 Lymphoma, Follicular 2 Glioma 2

Interventions

pembrolizumab 3 zimberelimab 1 tilsotolimod 1 sintilimab 1 sacituzumab govitecan 1 niraparib 1 encorafenib 1 cobimetinib 1 cedazuridine 1 binimetinib 1 atezolizumab 1 Radiosurgery 1 Proton Therapy 1 Nivolumab 1 Ipilimumab 1 Everolimus 1 Decitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Solid Tumor × atezolizumab × Clear all

NCT04185831 2024-08-22

MEGALiT

Uppsala University Hospital

Phase 2 Active not recruiting

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡